An additional cause of health care disparities: the variable clinical decisions of primary care doctors.
暂无分享,去创建一个
[1] India U.S. Consulate Chennai. U.S. Department of Health & Human Services , 2014 .
[2] J. Mckinlay,et al. Do Doctors Contribute to the Social Patterning of Disease , 2012, Medical care research and review : MCRR.
[3] J. Mckinlay,et al. The relative contribution of patient, provider and organizational influences to the appropriate diagnosis and management of diabetes mellitus. , 2011, Journal of evaluation in clinical practice.
[4] V. Basevi. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[5] Sara Arber,et al. It's About Time: Physicians' Perceptions of Time Constraints in Primary Care Medical Practice in Three National Healthcare Systems , 2010, Medical care.
[6] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[7] J. Mckinlay,et al. The intended and unintended consequences of clinical guidelines. , 2009, Journal of evaluation in clinical practice.
[8] J. Mckinlay,et al. Do physicians attend to base rates? Prevalence data and statistical discrimination in the diagnosis of coronary heart disease. , 2009, Health services research.
[9] A. Sehgal,et al. Eliminating Healthcare Disparities in America: Beyond the IOM Report , 2008, Annals of Internal Medicine.
[10] J. Dora,et al. Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.
[11] Silvio E. Inzucchi,et al. Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.
[12] Alan M Zaslavsky,et al. Testing for statistical discrimination by race/ethnicity in panel data for depression treatment in primary care. , 2008, Health services research.
[13] M. Peek,et al. Diabetes Health Disparities , 2007, Medical care research and review : MCRR.
[14] Peter Lindgren,et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary , 2007 .
[15] Chris M Kozma,et al. The National Guideline Clearinghouse. , 2006, Managed care interface.
[16] R. Steinbrook. Facing the diabetes epidemic--mandatory reporting of glycosylated hemoglobin values in New York City. , 2006, The New England journal of medicine.
[17] E. Guadagnoli,et al. The Influence of Physicians’ Practice Management Strategies and Financial Arrangements on Quality of Care Among Patients With Diabetes , 2004, Medical care.
[18] B. Fleming,et al. Variation in diabetes care among states: do patient characteristics matter? , 2002, Diabetes care.
[19] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.
[20] M. Laakso,et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.
[21] Robert Atkins,et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. , 2002, Diabetes care.
[22] M. Engelgau,et al. A Diabetes Report Card for the United States: Quality of Care in the 1990s , 2002, Annals of Internal Medicine.
[23] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[24] M. Harris,et al. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. , 2001, Diabetes care.
[25] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[26] J. Mckinlay,et al. US public health and the 21st century: diabetes mellitus , 2000, The Lancet.
[27] Kahn Cr. Diabetes: a strategic plan for the 21st century. , 1999 .
[28] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[29] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[30] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[31] K. Flegal,et al. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.
[32] M. Harris,et al. Undiagnosed NIDDM: Clinical and Public Health Issues , 1993, Diabetes Care.
[33] J. Eisenberg,et al. Physician Utilization: The State of Research About Physicians’ Practice Patterns , 1985, Medical care.
[34] Margaret J. Robertson,et al. Design and Analysis of Experiments , 2006, Handbook of statistics.
[35] J. Fradkin,et al. Confronting the urgent challenge of diabetes: an overview. , 2012, Health affairs.
[36] J. Mckinlay,et al. Clinical Vignettes in Health Services Research: Advantages and Limitations of Different Formats , 2012 .
[37] Mark E. Cowen,et al. Encyclopedia of medical decision making , 2009 .
[38] Richard A. Williams. Eliminating Healthcare Disparities in America , 2007 .
[39] J. Eisenberg,et al. Physician utilization: the state of research about physicians' practice patterns. , 2002, Medical care.
[40] Adrienne Y. Stith,et al. Unequal treatment: confronting racial and ethnic disparities in health care. , 2003 .
[41] L Devies,et al. Social factors , 1999, International Journal of Obesity.
[42] A. Baron. Experimental Designs , 1990, The Behavior analyst.